SIEMENS HEALTH ADR/050 (SHL1) — Capital Reinvestment Ratio
SIEMENS HEALTH ADR/050 (SHL1) has a Capital Reinvestment Ratio of 0.33x as of December 2025, meaning it reinvests 0% of its operating cash flow (€492.00 Million) in capital expenditures (€161.00 Million). See SHL1 net asset quality score to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
SIEMENS HEALTH ADR/050 Capital Reinvestment Ratio (2022–2024)
This chart tracks SIEMENS HEALTH ADR/050's Capital Reinvestment Ratio across 3 annual periods. Check how aggressively does SIEMENS HEALTH ADR/050 reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for SIEMENS HEALTH ADR/050 (2022–2024)
Year-by-year Capital Reinvestment Ratio for SIEMENS HEALTH ADR/050 from 2022 to 2024. For live market cap and broader valuation context, see SIEMENS HEALTH ADR/050 market capitalisation.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.25x | €2.83 Billion | €696.00 Million | ▼ -37.7% |
| 2023 | 0.40x | €2.12 Billion | €838.00 Million | ▲ +16.2% |
| 2022 | 0.34x | €2.50 Billion | €852.00 Million | — |